Skip to main content
Premium Trial:

Request an Annual Quote

RNAi CRO Cenix Bioscience Shuts Down

NEW YORK (GenomeWeb) – RNAi contract research firm Cenix Bioscience is shutting down, according to a statement on the company's website.

Cenix CEO and CSO Christopher Echeverri confirmed the situation, but declined to comment further.

The company was founded about 15 years ago to provide high-throughput target discovery and validation services for academic and industry partners, and also developed research products such as genome-wide siRNA libraries. The German company had also been exploring RNAi delivery technologies for in vivo applications, and in 2012 established a US subsidiary to help establish partnerships in North America.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.